CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
NATPRIME DN aims to enhance the delivery of nucleic acid therapeutics using nanoparticle-based adjuvants. The project focuses on developing targeted delivery systems to improve the effectiveness of RNA-based therapies and vaccines through innovative formulations and molecular targeting strategies.
Delivery of Nucleic Acid Therapeutics to desired organs has become the current challenge of biotechnological applications.
Advancements on the chemical synthesis or targeting ligands, formulation of complex lipid systems, and their bioassays are essential to establish new gene therapies.
Therefore, the main aim of NATPRIME DN is to establish a multidisciplinary training network on the emerging topic of nanoparticle-based adjuvants to deliver nucleic acid therapeutics (NAT).
In the last decade, g…
TECHNISCHE UNIVERSITEIT EINDHOVEN
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Denmark, Frederikssund
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Belgium, Gent
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
France, Bordeaux
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
